Chen, Y., Shen, Y., Zhang, M., Wu, J., Gao, S., Que, R., Yu, J., Tang, X., Bai, X., Liang, T. (2025). Updated results of the PATH study: Adjuvant therapy with donafenib plus a PD-1 inhibitor for patients with hepatocellular carcinoma at high risk of recurrence after resection.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.571